The effects of early and late administrations of hUC-MSCs on renal function (<b>Figure 1A and 1B</b>) and renal histology changes (<b>Figure 1C to F</b>igure 1I) of NOD-SCID mice s... by Te-Chao Fang (305300)

“…<p>(A) The levels of serum urea nitrogen and (B) the levels of serum creatinine. …”

The expulsion of <i>T</i>. <i>spiralis</i> is affected by the gut microbiota and dependent on the host’s mucosal immunity. by Chengyao Li (311264)

Decrease of <i>mlf</i>, <i>cwp1-3</i>, <i>myb2</i>, <i>wrky</i>, <i>pax1</i>, and <i>cdk2</i> gene expression by MLF knock down during encystation using strategy 1. by Zi-Qi Lin (6444350)

“…Fold change is calculated as the ratio of the difference between MLFko cell line and the control cell line, to which a value of 1 was assigned. Results are expressed as mean ± SD. …”

Comparison of the changes in HR (A), SBP (B), DP (C), and SpO2 (D) during maximal exercise test among the three oxygen conditions. by Kazufumi Hisamoto (21416905)

Table 1_Genetic susceptibility to gestational diabetes and its mild modification by bisphenol A and thyroid-stimulating hormone: findings from a South Chinese pregnancy cohort.docx by Yanyan Mao (1998469)

“…The protective effect ofPPARGC1A rs8192678 in GDM was confirmed and was non-linearly modified by sqrt-BPA levels. …”

Presentation 1_Genetic susceptibility to gestational diabetes and its mild modification by bisphenol A and thyroid-stimulating hormone: findings from a South Chinese pregnancy coho... by Yanyan Mao (1998469)

“…The protective effect ofPPARGC1A rs8192678 in GDM was confirmed and was non-linearly modified by sqrt-BPA levels. …”

Image 1_Genetic susceptibility to gestational diabetes and its mild modification by bisphenol A and thyroid-stimulating hormone: findings from a South Chinese pregnancy cohort.pdf by Yanyan Mao (1998469)

“…The protective effect ofPPARGC1A rs8192678 in GDM was confirmed and was non-linearly modified by sqrt-BPA levels. …”

Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, Canada by Genevieve Rocheleau (4455214)

“…A higher median income (aOR: 0.83, 0.77–0.89) and higher percentage of those with aboriginal ancestry (aOR: 0.85, 0.76–0.95) were census tract-level sociodemographic covariates associated with decreased access to DRT. …”

Fig 2 - by Susana Aideé González-Chávez (11495378)

Validation of DEGs in UVA-irradiated S cells that are involved in skin senescence. by Seong-Wook Seo (5641799)

“…<p>(A) KEGG analysis shows the list of DEGs involved in Toll-like receptor signaling pathway. …”

The gut microbiota is involved in intestinal homeostasis. by Chengyao Li (311264)

cART treatment of SweAPP N2a cells promotes mitochondrial dysfunction. by Lecia A. M. Brown (554752)

“…We found a significant decrease in ATP levels in cells treated with EFV or 3TC/AZT/EFV (***<i>P</i><0.001). …”

Baseline outcome measures for BL6 control and dy^2J mice at 12–15 weeks of age show decreased body weights, forelimb grip strength, vertical activity and increased heart... by Qing Yu (337275)

Effects of levofloxacin on the hind paws of DBA/1 mice. by Susana Aideé González-Chávez (11495378)

MRP3 silencing led to reduce excretion rates and increase intracellular demethoxycurcumin-<i>O</i>-glucuronides in HeLa1A1 cells. by Beibei Zhang (509356)

“…<p>(A) MRP3 transporter silencing inhibited the accumlated demethoxycurcumin-<i>O</i>-glucuronides (G1) in extracellular medium; (B) MRP3 transporter silencing decreased the excreted demethoxycurcumin-<i>O</i>-glucuronides (G2) in extracellular solution; (C) MRP3 silencing significantly reduced the excretion rates of G1 and G2; (D) MRP3 silencing resulted in evaluation of intracellular G1 and G2 levels; (E) MRP3 silencing decreased total cellular glucuronidation (G1 ang G2) of demethoxycurcumin; (F) Effects of gene silencing on the protein level of MRP3. …”

Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials by Tao Cheng (1235148)

“…The onabotulinumtoxinA-treated groups had a significantly decreased mean number of urinary incontinence episodes per week (at week 6) (onabotulinumtoxinA200U: MD: -10.72, 95% CI: -13.4 to -8.04, P<0.00001; 300 U: MD: -11.42, 95% CI: -13.91 to -8.93, P<0.00001), MDP (200 U: MD: -33.46, 95% CI: -39.74 to -27.18, P<0.00001; 300 U: MD: -31.72, 95% CI: -37.69 to -25.75, P<0.00001), and greater increased MCC (200 U: MD: 141.30, 95% CI: 121.28 to 161.32, P<0.00001; 300 U: MD: 151.39, 95% CI: 130.43 to 172.34, P<0.00001) compared to the placebo-treated groups. …”

CF-BECs infected with 2 x 10² CFU’s of PA demonstrate significant bacterial burden at 24 hours without affecting monolayer confluency. by Meghan J. Hirsch (16528311)

Transporter inhibitor MK571 inhibited the generation and excretion of demethoxycurcumin-<i>O</i>-glucuronides in HeLa1A1 cells. by Beibei Zhang (509356)

“…<p>(A) MK571 (5 and 20 μM) inhibited the excretion of demethoxycurcumin-<i>O</i>-glucuronides (G1) in extracellular medium; (B) Inhibitory effects of MK571 (5 and 20 μM) on the excretion of demethoxycurcumin-<i>O</i>-glucuronides (G2) in extracellular solution; (C) MK571 (5 and 20 μM) decreased the efflux excretion rates of G1 and G2; (D) MK571 (5 and 20 μM) evaluated the intracellular levels of G1 and G2; (E) MK571 (5 and 20 μM) reduced the overall formation (<i>f</i>_met) of G1 and G2 in HeLa1A1 cell; The concentration of demethoxycurcumin was 4 μM. …”

Depletion of <i>gon-1</i> causes INS-18 secretion defects. by Sawako Yoshina (375229)

Ca²⁺-sensitive cameleon YC3.60 ratiometric imaging shows that [Ca²⁺]_cyt levels are decreased and less steady in growing <i>rbohH-1 rbohJ-2</i> poll... by Aurélien Boisson-Dernier (490023)